Dyadic International, Inc. (DYAI)
NASDAQ: DYAI · Real-Time Price · USD
0.8200
+0.0150 (1.86%)
Feb 18, 2026, 4:00 PM EST - Market closed
Dyadic International Market Cap
Dyadic International has a market cap or net worth of $29.37 million as of February 19, 2026. Its market cap has decreased by -32.02% in one year.
Market Cap
29.37M
Enterprise Value
25.50M
1-Year Change
-32.02%
Ranking
Category
Stock Price
$0.82
Market Cap Chart
Since April 18, 2019, Dyadic International's market cap has decreased from $94.80M to $29.37M, a decrease of -69.02%. That is a compound annual growth rate of -15.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 18, 2026 | 29.30M | -13.82% |
| Dec 31, 2025 | 34.00M | -34.36% |
| Dec 31, 2024 | 51.80M | 11.64% |
| Dec 29, 2023 | 46.40M | 32.19% |
| Dec 30, 2022 | 35.10M | -72.34% |
| Dec 31, 2021 | 126.90M | -14.20% |
| Dec 31, 2020 | 147.90M | 4.89% |
| Dec 31, 2019 | 141.00M | 48.73% |
| Apr 18, 2019 | 94.80M | - |
View and export this data all the way back to 2019. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Atara Biotherapeutics | 32.09M |
| Jasper Therapeutics | 31.90M |
| Tempest Therapeutics | 31.82M |
| Werewolf Therapeutics | 31.73M |
| Reviva Pharmaceuticals Holdings | 30.45M |
| Kyntra Bio | 30.34M |
| Lantern Pharma | 30.20M |
| Rein Therapeutics | 29.44M |